Literature DB >> 6388348

Glucose production and utilization in children with glycogen storage disease type I.

E Tsalikian, P Simmons, J E Gerich, C Howard, M W Haymond.   

Abstract

Glucose turnover rates were estimated with [2H2]glucose in five children with glycogen storage disease type I (GSD I) during sequential withdrawal of an infusion of glucose to determine whether their hypoglycemia was the result of decreased glucose production or increased rates of glucose utilization. Plasma glucose concentrations were 78 +/- 5 mg/dl during infusion of glucose at 6 mg X kg-1 X min-1 and decreased to 53 +/- 3 and 45 +/- 7 mg/dl during the 3 and 1.5 mg X kg-1 X min-1 glucose infusions, respectively. Total glucose flux during the 6 mg X kg-1 X min-1 glucose infusion was 7.3 +/- 0.7 mg X kg-1 X min-1 and decreased with reduction in the rate of glucose infused. Endogenous glucose production increased with each decrease in the rate of exogenous glucose infused. Following discontinuation of glucose infusion, endogenous glucose production was 3.9 +/- 0.3 mg X kg-1 X min-1, a value that was lower (P less than 0.05) than that observed in overnight-fasted normal children (6.3 +/- 0.3 mg X kg-1 X min-1) but not statistically different from the Ra of normal children fasted for 30 h (4.1 +/- 0.5 mg X kg-1 X min-1). Thus, children with GSD have glucose production rates that are 40% lower than those of normal children fasted overnight but equal to those of normal children fasted 30 h. Rates of glucose utilization during the 6 mg X kg-1 X min-1 glucose infusion were higher (0.05 less than P less than 0.1) than those of overnight-fasted normal children, despite lower plasma glucose concentrations when expressed on a body weight basis but not when expressed on the basis of estimated brain weight.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6388348     DOI: 10.1152/ajpendo.1984.247.4.E513

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

Review 1.  Acute management of propionic acidemia.

Authors:  Kimberly A Chapman; Andrea Gropman; Erin MacLeod; Kathy Stagni; Marshall L Summar; Keiko Ueda; Nicholas Ah Mew; Jill Franks; Eddie Island; Dietrich Matern; Loren Pena; Brittany Smith; V Reid Sutton; Tiina Urv; Charles Venditti; Anupam Chakrapani
Journal:  Mol Genet Metab       Date:  2011-09-24       Impact factor: 4.797

2.  Glucose production rates in type 1 glycogen storage disease.

Authors:  J E Collins; K Bartlett; J V Leonard; A Aynsley-Green
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Estimation of glucose carbon recycling in children with glycogen storage disease: A 13C NMR study using [U-13C]glucose.

Authors:  B Kalderon; S H Korman; A Gutman; A Lapidot
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

4.  Inherited disorders of carbohydrate metabolism in children studied by 13C-labelled precursors, NMR and GC-MS.

Authors:  A Lapidot
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

5.  A potential role for muscle in glucose homeostasis: in vivo kinetic studies in glycogen storage disease type 1a and fructose-1,6-bisphosphatase deficiency.

Authors:  Hidde H Huidekoper; Gepke Visser; Mariëtte T Ackermans; Hans P Sauerwein; Frits A Wijburg
Journal:  J Inherit Metab Dis       Date:  2010-02-02       Impact factor: 4.982

6.  Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control.

Authors:  Fabian Peeks; Thomas A H Steunenberg; Foekje de Boer; M Estela Rubio-Gozalbo; Monique Williams; Rob Burghard; Fabienne Rajas; Maaike H Oosterveer; David A Weinstein; Terry G J Derks
Journal:  J Inherit Metab Dis       Date:  2017-04-10       Impact factor: 4.982

Review 7.  Flux analysis of inborn errors of metabolism.

Authors:  D-J Reijngoud
Journal:  J Inherit Metab Dis       Date:  2018-01-09       Impact factor: 4.982

8.  SGLT2 inhibition alleviated hyperglycemia, glucose intolerance, and dumping syndrome-like symptoms in a patient with glycogen storage disease type Ia: a case report.

Authors:  Daisuke Katayama; Hiroo Baba; Takashige Kuwabara; Jun Kido; Hiroshi Mitsubuchi; Shirou Matsumoto; Kimitoshi Nakamura
Journal:  J Med Case Rep       Date:  2021-02-16

9.  LPIN1 rhabdomyolysis: A single site cohort description and treatment recommendations.

Authors:  Navya Kanderi; Brian Kirmse; Debra S Regier; Kimberly A Chapman
Journal:  Mol Genet Metab Rep       Date:  2022-02-05

Review 10.  Dynamic Methods for Childhood Hypoglycemia Phenotyping: A Narrative Review.

Authors:  Alessandro Rossi; Martijn G S Rutten; Theo H van Dijk; Barbara M Bakker; Dirk-Jan Reijngoud; Maaike H Oosterveer; Terry G J Derks
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-17       Impact factor: 6.055

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.